Neurology Billing Services for Complex Diagnostics and Chronic Care

Neurology medical billing is diagnostic-dense and authorization-heavy in a way few specialties are, and both of those traits are where the revenue is won or lost. A neurology practice runs on EEGs, EMG and nerve conduction studies, prolonged evaluation-and-management services, and infusions — each carrying unit and coding rules that generalist billers routinely miscount, and much of it gated behind prior authorizations that have to land before the service, not after.

The diagnostics are the first place claims go wrong. EMG and nerve conduction studies are billed under study-based unit rules (the 95907–95913 range) where the count of nerves studied determines the code — get the count or the pairing wrong and the claim either underpays or denies. EEG has its own family of codes for routine, extended, and ambulatory studies, and prolonged services layer on top of complex office visits. None of it survives a generic scrubber; it takes a coder who knows neurology.

Authorization is the second. Neurology leans heavily on MRIs and on high-cost infusions — migraine biologics like the CGRP agents, IVIG, and others — that carriers require prior authorization for, often with step-therapy and documentation hurdles. A single infusion can be worth thousands, and if the authorization isn’t secured and documented before the drug goes in, the practice can eat the cost entirely. RevPath tracks these authorizations to approval and keeps the paper trail that protects the claim.

Neurology is also a chronic-care specialty, and much of its recurring revenue — care management for epilepsy, Parkinson’s, MS, and other ongoing conditions — goes under-captured when billing is treated as a visit-by-visit afterthought. The complexity of these patients supports higher E/M levels and care-management codes that practices frequently under-bill out of caution.

What’s included, specifically:

• EMG and nerve conduction study coding under current study-unit rules
• EEG (routine, extended, ambulatory) coding verified before submission
• Prolonged services and complex E/M leveling supported by documentation
• Prior authorization for advanced imaging and high-cost infusions, tracked to approval
• Infusion and drug (J-code) billing with unit accuracy
• Chronic-care management capture for ongoing neurological conditions
• Appeal-ready documentation on denied high-cost claims

Documentation is the hinge on which neurology reimbursement swings, because so much of the specialty’s revenue depends on justifying medical necessity to skeptical payers. A high-cost infusion, an advanced imaging study, or a prolonged-services claim all require documentation that ties the service to the diagnosis in the specific way the payer wants to see. RevPath works from that documentation rather than around it, so claims go out with the necessity story already told — and denials that do arrive are appealed with the record already in hand.

For a neurology practice, the result is fewer expensive surprises. When authorizations are secured before infusions, when diagnostic units are counted correctly, and when chronic-care coordination is finally captured, the revenue becomes predictable instead of lurching between big paydays and big write-offs. Monthly reporting shows exactly how the diagnostics and infusions are performing, so the practice can see its highest-value services actually converting to collected dollars.

Take a patient started on a migraine biologic. The revenue depends on a chain: the prior authorization approved and on file, the drug billed with the correct J-code and units, the administration coded properly, and the diagnosis supporting medical necessity. Break any link — an expired auth, a unit miscount — and a four-figure claim denies, with the practice potentially on the hook for the drug it already administered. RevPath manages the whole chain, so the infusion pays and the patient keeps their therapy without a billing interruption.

This depth matters most for neurology and multi-subspecialty specialty practices juggling diagnostics and infusions at volume. It pairs with clean credentialing and disciplined denial management, because in neurology the denials that hurt most are the expensive ones that have to be appealed correctly the first time.

The result is a first-pass clean claim rate near 98% even on diagnostic-heavy claims, prior-auth denials driven toward zero by working them before the service, and recurring chronic-care revenue that finally gets captured. For a neurology practice, that combination is often the difference between diagnostics that feel like a billing headache and diagnostics that reliably get paid.

Neurology bills like the complex specialty it is. RevPath codes it that way — precisely, and with the authorization work done up front.